Abstract:Synovial sarcoma (SyS) is driven by the expression of a chromosomal translocation-generated SS18::SSX fusion oncoprotein. This oncoprotein fuses the SSX carboxy terminal tail that binds ubiquitylated histone H2A (H2AK119ub) to the SS18 component of both canonical (CBAF) and non-canonical (GBAF, GLTSCR1-containing) BAF-family chromatin remodeling complexes, wherein SS18::SSX reprograms the epigenetic landscape. Mice that express SS18::SSX develop tumors that faithfully recapitulate human SyS histopathologically and molecularly, allowing dissection of transcriptional reprogramming in vivo. Here, we show that SS18::SSX redistributes GBAF complexes broadly to promoters and distal enhancers decorated by H2AK119ub, which uncharacteristically lack the transcription-silencing trimethylation of H3K27 that otherwise accompanies H2AK119ub. Fusion-GBAF instead associates with H2AK119ub and transcription-enabling H3K4 trimethylation (promoters), monomethylation (distal enhancers), and H3K27 acetylation (both). CBAF with the fusion redistributes away from typical loci, avoids H2AK119ub-bearing regions, and instead narrowly flanks transcription start sites (TSSs), co-distributed with polybromo BAF (PBAF). Accelerated tumorigenesis in our SyS mouse model followed deletion of Smarcb1 (PBAF and CBAF), Pbrm1 (PBAF-specific), and Arid1a or Arid1b (CBAF-specific). While tumors lacking Arid1a or Arid1b retained SyS character, loss of Smarcb1 or Pbrm1 resulted in tumors lacking SyS features. These findings suggest that SyS transcriptional reprogramming includes both improper GBAF localization and gene activation at H2AK119ub-bearing regulatory regions and improper gene silencing through loss of CBAF.

Condensate remodeling reorganizes innate SS18 in synovial sarcomagenesis

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas

Exclusion of HDAC1/2 complexes by oncogenic nuclear condensates

SS18::SSX redistributes BAF chromatin remodelers selectively to activate and repress transcription

Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming

Cell-of-origin epigenome underlies SS18::SSX-mediated transformation

Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial Sarcoma

Dissolution of Oncofusion Transcription Factor Condensates for Cancer Therapy.

SS18 Regulates Pluripotent-Somatic Transition Through Phase Separation

The interaction of SS 18 and β-catenin promotes tumorigenesis of synovial sarcoma

Identification of Shcbp1 As A Novel Downstream Target Gene of Ss18-Ssx1 and Its Functional Analysis in Progression of Synovial Sarcoma

The Clinical Implication of SS18 -SSX Fusion Gene in Synovial Sarcoma

The Interaction Of Ss18 And Beta-Catenin Promotes Tumorigenesis Of Synovial Sarcoma

Onco-condensates: formation, multi-component organization, and biological functions

Systematic Transcriptome Analysis of Synovial Sarcoma Reveals Novel Transcriptional And Post-Transcriptional Abnormalities

Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription

Chemical-induced Phase Transition and Global Conformational Reorganization of Chromatin

Synovial sarcoma X breakpoint 1 protein uses a cryptic groove to selectively recognize H2AK119Ub nucleosomes

Subnuclear Distribution of SSX Regulates Its Function.

SGF29 nuclear condensates reinforce cellular aging

Hotspot Mutations in the Structured ENL YEATS Domain Link Aberrant Transcriptional Condensates and Cancer.